Original Publication Date: 1 April, 2016
Publication / Source: INTERNATIONAL JOURNAL OF HEMATOLOGIC ONCOLOGY
Authors: Maziarz RT, Guérin A, Gauthier G et al.
Aim: To assess the 5-year healthcare resource utilization (HRU) and direct payer costs following allogeneic hematopoietic stem cell transplants (HSCTs) in acute lymphoblastic leukemia pediatric patients using data from two large US administrative databases. Patients & methods: Among the 209 patients with acute lymphoblastic leukemia, HRU and costs were described over the up to 5 years after the HSCT.